(Q48420572)

11 February 2018

title

Acute iboga alkaloid effects on extracellular serotonin (5-HT) levels in nucleus accumbens and striatum in rats. (English)

1 reference

11 February 2018

0 references

1 reference

1 reference

Wei D

1

1 reference

11 February 2018

Maisonneuve IM

series ordinal

2

1 reference

11 February 2018

Kuehne ME

series ordinal

3

1 reference

11 February 2018

Glick SD

series ordinal

4

1 reference

11 February 2018

language of work or name

English

0 references

publication date

1 August 1998

1 reference

11 February 2018

published in

Brain Research

1 reference

11 February 2018

volume

800

1 reference

11 February 2018

issue

2

1 reference

11 February 2018

page(s)

260-268

1 reference

11 February 2018

Serotonergic mechanisms of cocaine effects in humans.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900527-7

Ibogaine: a potent noncompetitive blocker of ganglionic/neuronal nicotinic receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900527-7

MDMA-induced neurotoxicity: parameters of degeneration and recovery of brain serotonin neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900527-7

The neurotoxic effects of p-chloroamphetamine in rat brain are blocked by prior depletion of serotonin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900527-7

Ibogaine modulates cocaine responses which are altered due to environmental habituation: in vivo microvoltammetric and behavioral studies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900527-7

Inhibitory effects of ibogaine on cocaine self-administration in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900527-7

Mechanisms of action of ibogaine and harmaline congeners based on radioligand binding studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900527-7

Serotonergic modulation of striatal dopamine measured with positron emission tomography (PET) and in vivo microdialysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900527-7

The role of the 5-HT2A and 5-HT2C receptors in the stimulus effects of hallucinogenic drugs. I: Antagonist correlation analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900527-7

Uptake inhibitors increase extracellular serotonin concentration measured by brain microdialysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900527-7

Ibogaine-like effects of noribogaine in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900527-7

18-Methoxycoronaridine, a non-toxic iboga alkaloid congener: effects on morphine and cocaine self-administration and on mesolimbic dopamine release in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900527-7

Effects of iboga alkaloids on morphine and cocaine self-administration in rats: relationship to tremorigenic effects and to effects on dopamine release in nucleus accumbens and striatum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900527-7

Effects of ibogaine on acute signs of morphine withdrawal in rats: independence from tremor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900527-7

Effects and aftereffects of ibogaine on morphine self-administration in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900527-7

Carrier-mediated release of serotonin by 3,4-methylenedioxymethamphetamine: implications for serotonin-dopamine interactions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900527-7

5-hydroxytryptamine uptake blockers attenuate the 5-hydroxytryptamine-releasing effect of 3,4-methylenedioxymethamphetamine and related agents.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900527-7

Preliminary findings with the indirect 5-HT agonist dexfenfluramine on heroin discrimination and self-administration in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900527-7

Addiction to cocaine and amphetamine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900527-7

Structure and function of the brain serotonin system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900527-7

An animal behavior model for studying central serotonergic synapses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900527-7

Rotational behaviour elicited by 5-HT in the rat: evidence for an inhibitory role of 5-HT in the substantia nigra and corpus striatum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900527-7

Serotonin may have neurotoxic properties

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900527-7

Break-points on a progressive ratio schedule reinforced by intravenous cocaine increase following depletion of forebrain serotonin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900527-7

Ibogaine possesses a selective affinity for σ2 receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900527-7

Acute and prolonged effects of ibogaine on brain dopamine metabolism and morphine-induced locomotor activity in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900527-7

Identification of a primary metabolite of ibogaine that targets serotonin transporters and elevates serotonin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900527-7

Properties of ibogaine and its principal metabolite (12-hydroxyibogamine) at the MK-801 binding site of the NMDA receptor complex.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900527-7

Pharmacotherapy in Alcoholism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900527-7

Ibogaine neurotoxicity: a re-evaluation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900527-7

Degeneration of Purkinje cells in parasagittal zones of the cerebellar vermis after treatment with ibogaine or harmaline

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900527-7

Stimulus effects of ibogaine in rats trained with yohimbine, DOM, or LSD

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900527-7

Light microscopic immunocytochemical evidence of converging serotonin and dopamine terminals in ventrolateral nucleus accumbens.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900527-7

The putative anti-addictive drug ibogaine is a competitive inhibitor of [3H]MK-801 binding to the NMDA receptor complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900527-7

Attenuation of alcohol intake by ibogaine in three strains of alcohol-preferring rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900527-7

Attenuation of alcohol consumption by a novel nontoxic ibogaine analogue (18-methoxycoronaridine) in alcohol-preferring rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900527-7

Fluoxetine pretreatment reduces breaking points on a progressive ratio schedule reinforced by intravenous cocaine self-administration in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900527-7

Tryptophan depletion and attenuation of cue-induced craving for cocaine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900527-7

Comparison of the behavioral effects of ibogaine from three sources: mediation of discriminative activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900527-7

Effects of 5,7-dihydroxytryptamine lesions of the nucleus accumbens on rat intravenous morphine self-administration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900527-7

Modification of behavioral effects of cocaine by selective serotonin and dopamine uptake inhibitors in squirrel monkeys.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900527-7

Drug-induced place preference in rats with 5,7-dihydroxytryptamine lesions of the nucleus accumbens.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900527-7

Distribution of serotonin-immunoreactivity in the central nervous system of the rat-cell bodies and terminals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900527-7

Receptor binding profile suggests multiple mechanisms of action are responsible for ibogaine's putative anti-addictive activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900527-7

Ritanserin, a 5-HT2 receptor antagonist, activates midbrain dopamine neurons by blocking serotonergic inhibition.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900527-7

Dorsal raphe cells with collateral projections to the caudate-putamen and substantia nigra: a fluorescent retrograde double labeling study in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900527-7

Synaptic regulation of mesocorticolimbic dopamine neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900527-7

Cerebral Pharmacokinetics of Tremor-Producing Harmala and Iboga Alkaloids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900527-7

10.1016/S0006-8993(98)00527-7

7 January 2021

Identifiers

DOI

1 reference

11 February 2018

1 reference

11 February 2018